0001485003-21-000196.txt : 20211004 0001485003-21-000196.hdr.sgml : 20211004 20211004192939 ACCESSION NUMBER: 0001485003-21-000196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211004 DATE AS OF CHANGE: 20211004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ryu Elly CENTRAL INDEX KEY: 0001860740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 211304653 MAIL ADDRESS: STREET 1: 245 FIRST STREET, SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_163339016370662.xml FORM 4 X0306 4 2021-10-01 0 0001485003 Sesen Bio, Inc. SESN 0001860740 Ryu Elly C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 0 1 0 0 Principal Accounting Officer Common Stock 2021-10-01 4 A 0 115000 0 A 126696 D Represents restricted stock units which vest in full on September 30, 2022, subject to recipient's continued employment through September 30, 2022. Each restricted stock unit represents a contingent right to receive one share of the Sesen Bio, Inc.'s common stock. /s/ Mark R. Sullivan, as attorney-in-fact 2021-10-04